Ji Fei, Liang Yao, Fu Shunjun, Chen Dubo, Cai XiuQin, Li Shaoqiang, Peng Baogang, Liang Lijian, Hua Yunpeng
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, PR China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, PR China; Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), PR China.
Department of Gastric and Pancreatic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
HPB (Oxford). 2017 Aug;19(8):695-705. doi: 10.1016/j.hpb.2017.04.008. Epub 2017 May 3.
Malnutrition and immunological status are associated with survival in many cancers. Prognostic nutritional index (PNI) and body mass index (BMI) are recognized immune-nutritional indices and associated with postoperative outcome in hepatocellular carcinoma (HCC) patients. However, this association is still controversial. Our aim was to determine whether the combination of PNI and BMI is better than either alone in HCC patients' prognosis.
Preoperative PNI and BMI, patient demographics, clinical and pathological data from 322 HCC patients were collected and analyzed.
Low PNI was correlated with age, cirrhosis, total bilirubin (TBIL) ≥34.2 μmol/L, and recurrence. Likewise, low BMI was associated with TBIL ≥34.2 μmol/L, portal vein tumor thrombi (PVTT), tumor size, tumor differentiation, TNM stage, and recurrence. Multivariate analysis identified TNM stage, PVTT, tumor size, PNI, and BMI as independent predictors of outcome in HCC patients. Low PNI combined with BMI (PNI + BMI) accurately predicted poorer outcome, particularly in patients with TNM stage I HCC. The predictive range of PNI + BMI was more sensitive than that of either alone.
preoperative PNI/BMI is an independent predictor of outcome for HCC patients, especially in patients with early stage HCC. Intriguingly, the PNI + BMI combination can enhance the accuracy of prognosis.
营养不良和免疫状态与多种癌症的生存率相关。预后营养指数(PNI)和体重指数(BMI)是公认的免疫营养指标,与肝细胞癌(HCC)患者的术后结局相关。然而,这种关联仍存在争议。我们的目的是确定PNI和BMI的组合在预测HCC患者预后方面是否优于单独使用其中任何一项。
收集并分析了322例HCC患者的术前PNI、BMI、患者人口统计学资料、临床和病理数据。
低PNI与年龄、肝硬化、总胆红素(TBIL)≥34.2 μmol/L及复发相关。同样,低BMI与TBIL≥34.2 μmol/L、门静脉癌栓(PVTT)、肿瘤大小、肿瘤分化、TNM分期及复发相关。多因素分析确定TNM分期、PVTT、肿瘤大小、PNI和BMI是HCC患者预后的独立预测因素。低PNI联合BMI(PNI + BMI)能准确预测较差的预后,尤其是TNM I期HCC患者。PNI + BMI的预测范围比单独使用其中任何一项更敏感。
术前PNI/BMI是HCC患者预后的独立预测因素,尤其是早期HCC患者。有趣的是,PNI + BMI组合可提高预后预测的准确性。